Massachusetts Financial Services’s Vanda Pharmaceuticals VNDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$836K Buy
177,050
+2,191
+1% +$10.3K ﹤0.01% 831
2025
Q1
$803K Sell
174,859
-3,988
-2% -$18.3K ﹤0.01% 817
2024
Q4
$857K Sell
178,847
-5,334
-3% -$25.6K ﹤0.01% 821
2024
Q3
$864K Buy
+184,181
New +$864K ﹤0.01% 801
2024
Q2
Sell
-136,340
Closed -$560K 894
2024
Q1
$560K Sell
136,340
-303
-0.2% -$1.25K ﹤0.01% 806
2023
Q4
$577K Sell
136,643
-4,316
-3% -$18.2K ﹤0.01% 794
2023
Q3
$609K Sell
140,959
-5,401
-4% -$23.3K ﹤0.01% 792
2023
Q2
$965K Sell
146,360
-3,449
-2% -$22.7K ﹤0.01% 751
2023
Q1
$1.02M Sell
149,809
-4,234
-3% -$28.7K ﹤0.01% 755
2022
Q4
$1.14M Buy
154,043
+3,261
+2% +$24.1K ﹤0.01% 765
2022
Q3
$1.49M Sell
150,782
-1,375
-0.9% -$13.6K ﹤0.01% 755
2022
Q2
$1.66M Buy
152,157
+768
+0.5% +$8.37K ﹤0.01% 743
2022
Q1
$1.71M Buy
151,389
+1,554
+1% +$17.6K ﹤0.01% 765
2021
Q4
$2.35M Sell
149,835
-3,035
-2% -$47.6K ﹤0.01% 764
2021
Q3
$2.62M Sell
152,870
-2,006
-1% -$34.4K ﹤0.01% 754
2021
Q2
$3.33M Buy
154,876
+71,101
+85% +$1.53M ﹤0.01% 736
2021
Q1
$1.26M Sell
83,775
-14,389
-15% -$216K ﹤0.01% 821
2020
Q4
$1.29M Sell
98,164
-987
-1% -$13K ﹤0.01% 778
2020
Q3
$958K Buy
+99,151
New +$958K ﹤0.01% 777
2019
Q1
Sell
-58,810
Closed -$1.54M 872
2018
Q4
$1.54M Buy
58,810
+4,587
+8% +$120K ﹤0.01% 732
2018
Q3
$1.25M Buy
+54,223
New +$1.25M ﹤0.01% 769
2018
Q2
Sell
-12,957
Closed -$218K 867
2018
Q1
$218K Buy
12,957
+200
+2% +$3.37K ﹤0.01% 830
2017
Q4
$194K Buy
12,757
+1,790
+16% +$27.2K ﹤0.01% 837
2017
Q3
$196K Buy
+10,967
New +$196K ﹤0.01% 833
2017
Q2
Sell
-45,562
Closed -$638K 884
2017
Q1
$638K Buy
45,562
+541
+1% +$7.58K ﹤0.01% 790
2016
Q4
$718K Buy
+45,021
New +$718K ﹤0.01% 793